NLS Pharmaceutics Announces Positive Interim Top-Line Data for Quilience® (Mazindol ER) in Patients with Narcolepsy
NLS Pharmaceutics to Present Interim Top-Line Data for Quilience® (Mazindol ER) in Patients with Narcolepsy at the World Sleep Congress in March 2022